LISINOPRIL HEXAL lisinopril 10mg tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

lisinopril dihydrate, Quantity: 11.11 mg (Equivalent: lisinopril, Qty 10 mg)

Disponible desde:

Medis Pharma Pty Ltd

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: mannitol; calcium hydrogen phosphate dihydrate; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; iron oxide red; iron oxide black; iron oxide yellow

Vía de administración:

Oral

Unidades en paquete:

30 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Hypertension: Lisinopril Hexal is indicated in the treatment of mild to moderate essential hypertension. It may be used alone or concomitantly with other classes of antihypertensive agents. Sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. Congestive heart failure: Lisinopril Hexal is also indicated in the treatment of heart failure. In such patients, it is recommended that Lisinopril Hexal be administered together with a diuretic. Acute myocardial infarction: Lisinopril Hexal is indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmHg. Lisinopril Hexal may be initiated within 24 hours of an acute myocardial infarction.

Resumen del producto:

Visual Identification: LIGHT PINK, ROUND, BICONVEX SCORED TABLET; Container Type: Blister Pack; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Registered

Fecha de autorización:

2002-11-25